Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Central Nervous System Neoplasms × Memantine × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Central Nervous System Neoplasms 1

Interventions

motexafin gadolinium 1 Vincristine 1 Rituximab 1 Radiotherapy 1 Procarbazine 1 Pemetrexed 1 Methotrexate 1 Memantine 1 Donepezil 1 Cytarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04217694 2024-11-21

Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors

Mayo Clinic

Phase EARLY_PHASE1 Completed

Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡